Bubendorf/Basel, May 4, 2018 – Bachem (SIX: BANB) announced today that the UK site has been successfully certified to ISO13485. Bachem is the world’s leader in custom peptide synthesis for applications ranging from research and development to the production of active ingredients for authorized products under cGMP conditions.

“We are delighted to announce that our site in St Helens successfully obtained certification in February 2018,” said Dr. Anne-Kathrin Stoller, Chief Marketing Officer at Bachem Holding AG. “ISO13485 defines the requirements that comprehensive quality management systems for medical devices – including in vitro diagnostics – have to satisfy, and guarantees transparency and continuous improvement of all systems and processes. This underscores Bachem’s across-the-board commitment to quality on behalf of customers and partners. Now that we have two ISO-certified sites in Europe and the USA, we will be able to serve customers in the diagnostics business worldwide even more effectively.”